Michele Compagno
11 – 20 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Anti-phospholipid antibodies and renal involvement are the main features associated with adverse pregnancy outcomes in patients with Systemic Lupus Erythematosus. A long-term longitudinal study in Southern Sweden
2020) 12th European Lupus Meeting(
- Contribution to conference › Abstract
-
Mark
Abatacept in rheumatoid arthritis : Survival on drug, clinical outcomes, and their predictors - Data from a large national quality register
(
- Contribution to journal › Article
-
Mark
TNF-alpha inhibitors for juvenile idiopathic arthritis
(
- Contribution to journal › Scientific review
-
Mark
Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus : An Observational Study from a Single Centre in Sweden
(
- Contribution to journal › Article
-
Mark
Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Adverse pregnancy outcomes (APOs) after mult-professional follow-up ín women affected by Systemic Lupus Erythematosus (SLE). : Report from a single center in Southern Sweden.
2019) EULAR 2019(
- Contribution to conference › Abstract
- 2016
-
Mark
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
(
- Contribution to journal › Article
- 2015
-
Mark
Studies on anti-dsDNA Antibodies and other potential biomarkers in Systemic Lupus Erythematosus
(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study.
(
- Contribution to journal › Article
- 2013
-
Mark
Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
(
- Contribution to journal › Article